The tyrosine kinase Janus kinase 2 (JAK2) is directly linked to the pathogenesis of MPN with the identification of JAK2 V617F as a recurring gain-of function mutation [3]. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.